Ali Naderi

Oncology

2100 N Capitol St
Iowa City, IA 52242

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.

Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.

Journal: Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology

Published: June 29, 2020

Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.

Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.

Journal: Cancer reports (Hoboken, N.J.)

Published: May 05, 2020

Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.

Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.

Journal: Experimental cell research

Published: December 18, 2018

SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.

SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.

Journal: Molecular oncology

Published: January 25, 2018

C1orf64 is a novel androgen receptor target gene and coregulator that interacts with 14-3-3 protein in breast cancer.

C1orf64 is a novel androgen receptor target gene and coregulator that interacts with 14-3-3 protein in breast cancer.

Journal: Oncotarget

Published: January 31, 2017

Prolactin-Induced Protein regulates cell adhesion in breast cancer.

Prolactin-Induced Protein regulates cell adhesion in breast cancer.

Journal: Biochemical and biophysical research communications

Published: November 03, 2015

Prolactin-induced protein in breast cancer.

Prolactin-induced protein in breast cancer.

Journal: Advances in experimental medicine and biology

Published: December 05, 2014

Coagulation factor VII is regulated by androgen receptor in breast cancer.

Coagulation factor VII is regulated by androgen receptor in breast cancer.

Journal: Experimental cell research

Published: August 11, 2014

Prolactin-induced protein is required for cell cycle progression in breast cancer.

Prolactin-induced protein is required for cell cycle progression in breast cancer.

Journal: Neoplasia (New York, N.Y.)

Published: January 16, 2014

Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer.

Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer.

Journal: Breast cancer research : BCR

Published: May 14, 2012

Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer.

Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer.

Journal: Neoplasia (New York, N.Y.)

Published: February 02, 2012

Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer.

Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer.

Journal: Breast cancer research : BCR

Published: February 08, 2011

Showing 1-12 of 19

Last Updated: 09/26/2026